Competing Interests: The author has been involved in clinical trials of albendazole and nitazoxanide, and has received research funding for these trials from SmithKline Beecham Pharmaceuticals and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback